Skip to main content
. 2024 Nov 12;16(11):1447. doi: 10.3390/pharmaceutics16111447
ASO antisense oligonucleotide;
cEt 2′,4′-constrained 2′-O-ethyl;
ENA 2′-O,4′-C-ethylene-bridged nucleic acid;
FA fatty acid;
GFP green fluorescent protein;
HAS human serum albumin;
LNA locked nucleic acid;
ON oligonucleotide;
PB boranophosphate;
PC alkylphosphanate;
PG phosphoryl guanidine;
PMO morpholino oligonucleotide;
PN phosphoramidate;
PNA peptide nucleic acid;
POR phosphotriester;
PS thiophosphate;
siRNA small interfering RNA;
tcDNA tricyclo-DNA;
tON therapeutic oligonucleotide;
2′-OMe 2′-O-methyl;
2′-MOE 2′-O-methoxyethyl;
2′F 2′-fluoro